Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Ozdede A, Yazici H. N Engl J Med 2022;386:1766.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozdede A, Yazici H. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:1766.
PMID: 35507490